TY  - JOUR
AU  - Vega-Garcia, Nerea
AU  - Perez-Jaume, Sara
AU  - Esperanza-Cebollada, Elena
AU  - Vicente-Garces, Clara
AU  - Torrebadell, Montserrat
AU  - Jimenez-Velasco, Antonio
AU  - Ortega, Margarita
AU  - Llop, Marta
AU  - Abad, Lorea
AU  - Vagace, Jose Manuel
AU  - Minguela, Alfredo
AU  - Pratcorona, Marta
AU  - Sanchez-Garcia, Joaquin
AU  - Garcia-Calderon, Clara B
AU  - Gomez-Casares, Maria Teresa
AU  - Martin-Clavero, Estela
AU  - Escudero, Adela
AU  - Riñon-Martinez-Gallo, Marta
AU  - Muñoz, Luz
AU  - Velasco, Maria Rosario
AU  - Garcia-Morin, Marina
AU  - Catala, Albert
AU  - Pascual, Antonia
AU  - Velasco, Pablo
AU  - Fernandez, Jose Mª
AU  - Lassaletta, Alvaro
AU  - Fuster, Jose Luis
AU  - Badell, Isabel
AU  - Molinos-Quintana, Agueda
AU  - Molines, Antonio
AU  - Guerra-Garcia, Pilar
AU  - Perez-Martinez, Antonio
AU  - Garcia-Abos, Miriam
AU  - Robles-Ortiz, Reyes
AU  - Pisa, Sandra
AU  - Adan, Rosa
AU  - Diaz-de-Heredia, Cristina
AU  - Dapena, Jose Luis
AU  - Rives, Susana
AU  - Ramirez-Orellana, Manuel
AU  - Camos, Mireia
PY  - 2021
DO  - 10.3389/fped.2020.614521
SN  - 2296-2360
UR  - http://hdl.handle.net/10668/17213
T2  - Frontiers in pediatrics
AB  - Robust and applicable risk-stratifying genetic factors at diagnosis in pediatric T-cell acute lymphoblastic leukemia (T-ALL) are still lacking, and most protocols rely on measurable residual disease (MRD) assessment. In our study, we aimed to analyze...
LA  - en
PB  - Frontiers Research Foundation
KW  - NOTCH1
KW  - T-cell acute lymphoblastic leukemia
KW  - Flow cytometry
KW  - Measurable (minimal) residual disease
KW  - Oncogenetics
KW  - Pediatrics
KW  - Risk-factors
KW  - F-Box-WD repeat-containing protein 7
KW  - Precursor T-cell lymphoblastic leukemia-lymphoma
KW  - Flow cytometry
KW  - Homozygote
KW  - Sequence deletion
KW  - Risk factors
KW  - T-lymphocytes
TI  - Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment.
TY  - Research article
VL  - 8
ER  -